全文获取类型
收费全文 | 1634篇 |
免费 | 108篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 46篇 |
妇产科学 | 43篇 |
基础医学 | 219篇 |
口腔科学 | 39篇 |
临床医学 | 121篇 |
内科学 | 296篇 |
皮肤病学 | 23篇 |
神经病学 | 231篇 |
特种医学 | 89篇 |
外科学 | 263篇 |
综合类 | 18篇 |
预防医学 | 128篇 |
眼科学 | 40篇 |
药学 | 79篇 |
中国医学 | 6篇 |
肿瘤学 | 96篇 |
出版年
2023年 | 13篇 |
2022年 | 11篇 |
2021年 | 28篇 |
2020年 | 14篇 |
2019年 | 32篇 |
2018年 | 30篇 |
2017年 | 33篇 |
2016年 | 31篇 |
2015年 | 33篇 |
2014年 | 36篇 |
2013年 | 73篇 |
2012年 | 72篇 |
2011年 | 64篇 |
2010年 | 38篇 |
2009年 | 56篇 |
2008年 | 92篇 |
2007年 | 84篇 |
2006年 | 90篇 |
2005年 | 82篇 |
2004年 | 67篇 |
2003年 | 62篇 |
2002年 | 51篇 |
2001年 | 58篇 |
2000年 | 50篇 |
1999年 | 53篇 |
1998年 | 25篇 |
1997年 | 21篇 |
1996年 | 21篇 |
1995年 | 17篇 |
1994年 | 11篇 |
1993年 | 14篇 |
1992年 | 53篇 |
1991年 | 21篇 |
1990年 | 28篇 |
1989年 | 21篇 |
1988年 | 19篇 |
1987年 | 24篇 |
1986年 | 20篇 |
1985年 | 27篇 |
1984年 | 12篇 |
1983年 | 9篇 |
1981年 | 7篇 |
1980年 | 15篇 |
1979年 | 13篇 |
1978年 | 13篇 |
1976年 | 10篇 |
1974年 | 10篇 |
1973年 | 18篇 |
1971年 | 11篇 |
1970年 | 13篇 |
排序方式: 共有1747条查询结果,搜索用时 12 毫秒
81.
Introduction
Ischemia-reperfusion (IR) kidney damage is an important factor for allograft survival in kidney transplantation. Recently it has been shown that immune factors from donor-derived cells are important in IR injury. The aim of this article was to evaluate the impact of short-term immunosuppressive treatment of the donor over a time frame relevant to cadaveric transplantation on IR damage to the rat kidney.Methods
Male Sprague-Dawley rats served as donors and recipients. Three experimental groups were evaluated according to the donor treatment (n = 6); control (no treatment); sirolimus (1 mg/kg orally) or FTY720 (1 mg/kg intravenously) at 6 or 1 hours prior to left nephrectomy. Kidneys were flushed with cold Euro-Collins solution and after 2 hours transplanted using microsurgical techniques concomittant with a left nephrectomy. After 48 hours (day 0), we removed the right kidney. Serum creatinine (SCr) was determined daily thereafter as well as differential leukocyte counts prior to donor nephrectomy and sirolimus plasma levels thereafter.Results
No difference was observed in SCr on day 1: control (3.97 ± 0.73 mg/dL), sirolimus (4.02 ± 1.44 mg/dL) and FTY 720 (3.27 ± 1.79 mg/dL; P = NS), or thereafter. Mortality was 50% in each group. Animals receiving FTY 720 showed a significant reduction in lymphocyte count (8.0 ± 3.1 to 1.1 ± 0.3 (P < .01). Sirolimus levels were 9.3 ± 1.5 ng/mL.Conclusion
We concluded that immunosuppressive treament of the donor within a time frame relevant to cadaveric kidney transplantation did not offer a benefit in terms of preventing IR injury. 相似文献82.
T-cell dysregulation in patients with hyperprolactinemia: effect of bromocriptine treatment 总被引:1,自引:0,他引:1
A Vidaller L Llorente F Larrea J P Mendez J Alcocer-Varela D Alarcon-Segovia 《Clinical immunology and immunopathology》1986,38(3):337-343
We studied four patients with tumoral hyperprolactinemia and normal ovarian function before and after prolactine levels had become normal with treatment with bromocriptine (BrC), a dopamine agonist that inhibits prolactin release. Their proliferative responses to concanavalin A, pokeweed mitogen, and, to a lesser extent, phytohemagglutinin, their spontaneous and concanavalin A-induced suppression, and their production of interleukin 2 were found to be decreased and to correct partially or completely after bromocriptine treatment. The T-cell response to interleukin 2 was low in two patients in whom it increased after BrC treatment. These findings give insight on the immunomodulatory role of prolactin in vivo. 相似文献
83.
Diehl KM Green EM Weinberg A Frederick WA Holmes DR Green B Morris A Kuerer HM Beltran RA Mendez J Gines V Ota DM Nelson H Newman LA 《Annals of surgical oncology》2011,18(13):3544-3550
Background
The clinical trials mechanism of standardized treatment and follow-up for cancer patients with similar stages and patterns of disease is the most powerful approach available for evaluating the efficacy of novel therapies, and clinical trial participation should protect against delivery of care variations associated with racial/ethnic identity and/or socioeconomic status. Unfortunately, disparities in clinical trial accrual persist, with African Americans (AA) and Hispanic/Latino Americans (HA) underrepresented in most studies.Study Design
We evaluated the accrual patterns for 10 clinical trials conducted by the American College of Surgeons Oncology Group (ACOSOG) 1999–2009, and analyzed results by race/ethnicity as well as by study design.Results
Eight of 10 protocols were successful in recruiting AA and/or HA participants; three of four randomized trials were successful. Features that were present among all of the successfully recruiting protocols were: (1) studies designed to recruit patients with regional or advanced-stage disease (2 of 2 protocols); and (2) studies that involved some investigational systemic therapy (3 of 3 protocols).Discussion
AA and HA cancer patients can be successfully accrued onto randomized clinical trials, but study design affects recruitment patterns. Increased socioeconomic disadvantages observed within minority-ethnicity communities results in barriers to screening and more advanced cancer stage distribution. Improving cancer early detection is critical in the effort to eliminate outcome disparities but existing differences in disease burden results in diminished eligibility for early-stage cancer clinical trials among minority-ethnicity patients. 相似文献84.
We have read the recent comprehensive review by Cruz et al.[1] regarding the targeting of receptor tyrosine kinases andtheir therapeutic perspectives in head and neck squamous cellcarcinomas (HNSCC). The major focus of this report was epidermalgrowth factor receptor (EGFR) biology and targeting. However,we feel 相似文献
85.
86.
87.
Poderoso C Paz C Gorostizaga A Cornejo Maciel F Mendez CF Podesta EJ 《Endocrine research》2002,28(4):319-323
PP1 and PP2A are members of the protein serine/threonine phosphatases (PPs) family and their activities have been proposed as a requirement for hormone- and cAMP-regulated steroid synthesis. These findings raise the question whether the PPs activity is increased by hormonal action in steroidogenic systems. Thus, the aim of the study was to evaluate the action of cAMP on the activity of PP1 and PP2A in MA-10 Leydig cells. Our results demonstrate that 8Br-cAMP stimulation produces a transient inhibition of PP2A activity. In contrast, PP1 activity remains unchangeable. As reported in other steroidogenic cells, cAMP-induced steroidogenesis in MA-10 cells is reduced by Cantharidin (Can) and also by Calyculin A (CA), two chemically unrelated PP1/PP2A inhibitors (data not shown). Taking into account the inhibitory effect of cAMP treatment on PP2A activity, the latest findings result paradoxical. Therefore, we next evaluated the action of these compounds on total protein synthesis. Can 10(-5) M and CA 10(-7) M markedly reduced total protein synthesis (35 and 50% respectively) in MA-10 cells, measured by 35S-methonine incorporation. These results suggest that hormone-dependent steroidogenesis is working through inhibition of PP2A-dependent dephosphorylation and the effect of PP1/PP2A inhibitors on steroidogenesis may be due to a general inhibition of protein synthesis rather than to a specific action on StAR protein induction. 相似文献
88.
Soy-based formulae and infant growth and development: a review 总被引:3,自引:0,他引:3
Soy-based infant formulae, initially developed for infants who were lactose intolerant or allergic to cow's milk-based formulae, now account for >25% of the infant formulae sold in the United States. Formulations have changed over the years to improve digestibility, the stability and availability of minerals, and protein quality. Recent concerns have been raised regarding the phytoestrogenic isoflavone content of soy-based formulae. A systematic review of the literature was conducted to evaluate various measures of infant health and development in clinical studies comparing modern soy-based formulae with other diets and to document areas in which further research seems warranted. Results suggest that modern soy-based formulae support normal growth and nutritional status in healthy term infants in y 1 of life. However, there are very limited data on sexual and reproductive development or outcomes such as immune function, visual acuity/cognitive development and thyroid function. Available data do not provide evidence of meaningful differences in timing of maturation, sexual development or fertility in adolescents or adults. Nonetheless, given evidence suggesting that early exposure to soy and/or isoflavones might have long-term effects, further research following infants fed soy-based formulae into adulthood is warranted. 相似文献
89.
90.
Abasic sites in HeLa cell DNA were increased in frequency by exposing the cells to lucanthone. Cell growth in the presence of lucanthone caused progressive accumulation of abasic sites and loss of cellular DNA. After 2 hr in 8 microM lucanthone, the abundance of abasic sites was 2.4 fold greater than the background of 9.9 +/- 2.0 SE abasic sites/10(6) nucleotides; 80 microM lucanthone in the growth medium increased the level 12.6 +/- 2.5 SE fold and decreased the DNA content in HeLa cells to one-half of the value obtained in untreated cells. The frequency of abasic sites in cellular DNA was determined by the aldehyde reactive probe method, with reference to abasic sites created in plasmid pBR322. The ability of lucanthone to inhibit the normal repair of abasic sites might reflect inhibition of apurinic/apyrimidinic endonuclease (HAP1) by the drug, thereby preventing an early step in the base excision repair pathway. Unrepaired abasic sites prevalent after ionizing radiation are cytotoxic lesions that promote DNA strand breaks. These results suggest a rationale for the joint lethal effects of lucanthone and ionizing radiation in cells and the accelerated tumor regression observed in cancer patients who received the combined therapy. 相似文献